Source: Owler

Enzo Biochem, Inc.: Enzo's revenue changed from $31.91M in Jul 2024 to $30.31M in Oct 2024

Enzo’s Trailing Twelve Months revenue changed from $31.91M in Jul 2024 to $30.31M in Oct 2024 decreasing 5.0% in this time period.

Read full article »

Enzo Biochem, Inc.'s Competitors | Enzo Biochem, Inc.'s News | Enzo Biochem, Inc.'s Financials

Followers on Owler

206

Annual Revenue

$25-100M

Employees

100-250

Interim-CEO

Kara Cannon

CEO Approval Rating

82/100

Enzo is a New York-based biotechnology company that develops diagnostics tests for the treatment of cancer, diabetes, HIV, uveitis, and inflammatory bowel diseases.